Literature DB >> 26582133

Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.

Natassia M Vieira1, Ingegerd Elvers2, Matthew S Alexander3, Yuri B Moreira4, Alal Eran5, Juliana P Gomes6, Jamie L Marshall7, Elinor K Karlsson8, Sergio Verjovski-Almeida9, Kerstin Lindblad-Toh2, Louis M Kunkel10, Mayana Zatz11.   

Abstract

Duchenne muscular dystrophy (DMD), caused by mutations at the dystrophin gene, is the most common form of muscular dystrophy. There is no cure for DMD and current therapeutic approaches to restore dystrophin expression are only partially effective. The absence of dystrophin in muscle results in dysregulation of signaling pathways, which could be targets for disease therapy and drug discovery. Previously, we identified two exceptional Golden Retriever muscular dystrophy (GRMD) dogs that are mildly affected, have functional muscle, and normal lifespan despite the complete absence of dystrophin. Now, our data on linkage, whole-genome sequencing, and transcriptome analyses of these dogs compared to severely affected GRMD and control animals reveals that increased expression of Jagged1 gene, a known regulator of the Notch signaling pathway, is a hallmark of the mild phenotype. Functional analyses demonstrate that Jagged1 overexpression ameliorates the dystrophic phenotype, suggesting that Jagged1 may represent a target for DMD therapy in a dystrophin-independent manner. PAPERCLIP.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DMD; Jagged1; dystrophin; genetic modifier; muscle

Mesh:

Substances:

Year:  2015        PMID: 26582133      PMCID: PMC4668935          DOI: 10.1016/j.cell.2015.10.049

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  55 in total

1.  Constitutive Notch activation upregulates Pax7 and promotes the self-renewal of skeletal muscle satellite cells.

Authors:  Yefei Wen; Pengpeng Bi; Weiyi Liu; Atsushi Asakura; Charles Keller; Shihuan Kuang
Journal:  Mol Cell Biol       Date:  2012-04-09       Impact factor: 4.272

2.  Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.

Authors:  Luca Bello; Luisa Piva; Andrea Barp; Antonella Taglia; Esther Picillo; Gessica Vasco; Marika Pane; Stefano C Previtali; Yvan Torrente; Elisabetta Gazzerro; Maria Chiara Motta; Gaetano S Grieco; Sara Napolitano; Francesca Magri; Adele D'Amico; Guja Astrea; Sonia Messina; Maria Sframeli; Gian Luca Vita; Patrizia Boffi; Tiziana Mongini; Alessandra Ferlini; Francesca Gualandi; Gianni Soraru'; Mario Ermani; Giuseppe Vita; Roberta Battini; Enrico Bertini; Giacomo P Comi; Angela Berardinelli; Carlo Minetti; Claudio Bruno; Eugenio Mercuri; Luisa Politano; Corrado Angelini; Eric P Hoffman; Elena Pegoraro
Journal:  Neurology       Date:  2012-06-27       Impact factor: 9.910

3.  Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.

Authors:  Jarrod E Church; Jennifer Trieu; Annabel Chee; Timur Naim; Stefan M Gehrig; Séverine Lamon; Corrado Angelini; Aaron P Russell; Gordon S Lynch
Journal:  Exp Physiol       Date:  2014-01-17       Impact factor: 2.969

4.  Muscular dystrophy in a litter of golden retriever dogs.

Authors:  J N Kornegay; S M Tuler; D M Miller; D C Levesque
Journal:  Muscle Nerve       Date:  1988-10       Impact factor: 3.217

5.  Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin.

Authors:  M Zatz; R C M Pavanello; M Lazar; G L Yamamoto; N C V Lourenço; A Cerqueira; L Nogueira; M Vainzof
Journal:  Neuromuscul Disord       Date:  2014-06-10       Impact factor: 4.296

Review 6.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

7.  Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.

Authors:  Eder Zucconi; Marcos Costa Valadares; Natássia M Vieira; Carlos R Bueno; Mariane Secco; Tatiana Jazedje; Helga Cristina Almeida da Silva; Mariz Vainzof; Mayana Zatz
Journal:  Neuromuscul Disord       Date:  2009-11-26       Impact factor: 4.296

8.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

Review 9.  The Pathogenesis and Therapy of Muscular Dystrophies.

Authors:  Simon Guiraud; Annemieke Aartsma-Rus; Natassia M Vieira; Kay E Davies; Gert-Jan B van Ommen; Louis M Kunkel
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-06-04       Impact factor: 8.929

10.  Direct cell-cell contact with the vascular niche maintains quiescent neural stem cells.

Authors:  Cristina Ottone; Benjamin Krusche; Ariadne Whitby; Melanie Clements; Giorgia Quadrato; Mara E Pitulescu; Ralf H Adams; Simona Parrinello
Journal:  Nat Cell Biol       Date:  2014-10-05       Impact factor: 28.824

View more
  63 in total

Review 1.  Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials.

Authors:  Yuko Shimizu-Motohashi; Shouta Miyatake; Hirofumi Komaki; Shin'ichi Takeda; Yoshitsugu Aoki
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Deletion of Pofut1 in Mouse Skeletal Myofibers Induces Muscle Aging-Related Phenotypes in cis and in trans.

Authors:  Deborah A Zygmunt; Neha Singhal; Mi-Lyang Kim; Megan L Cramer; Kelly E Crowe; Rui Xu; Ying Jia; Jessica Adair; Isabel Martinez-Pena Y Valenzuela; Mohammed Akaaboune; Peter White; Paulus M Janssen; Paul T Martin
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

Review 3.  Satellite Cells in Muscular Dystrophy - Lost in Polarity.

Authors:  Natasha C Chang; Fabien P Chevalier; Michael A Rudnicki
Journal:  Trends Mol Med       Date:  2016-05-05       Impact factor: 11.951

Review 4.  Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies.

Authors:  Rylie M Hightower; Matthew S Alexander
Journal:  Muscle Nerve       Date:  2017-09-22       Impact factor: 3.217

5.  Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.

Authors:  Natassia M Vieira; Janelle M Spinazzola; Matthew S Alexander; Yuri B Moreira; Genri Kawahara; Devin E Gibbs; Lillian C Mead; Sergio Verjovski-Almeida; Mayana Zatz; Louis M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

6.  Immunoglobulin therapy ameliorates the phenotype and increases lifespan in the severely affected dystrophin-utrophin double knockout mice.

Authors:  Bruno Ghirotto Nunes; Flávio Vieira Loures; Heloisa Maria Siqueira Bueno; Erica Baroni Cangussu; Ernesto Goulart; Giuliana Castello Coatti; Elia Garcia Caldini; Antonio Condino-Neto; Mayana Zatz
Journal:  Eur J Hum Genet       Date:  2017-10-27       Impact factor: 4.246

7.  Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions.

Authors:  Madhurima Saha; Satomi Mitsuhashi; Michael D Jones; Kelsey Manko; Hemakumar M Reddy; Christine C Bruels; Kyung-Ah Cho; Christina A Pacak; Isabelle Draper; Peter B Kang
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

Review 8.  Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease.

Authors:  Albert E Almada; Amy J Wagers
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03-09       Impact factor: 94.444

9.  Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.

Authors:  M V Pelatti; J P A Gomes; N M S Vieira; E Cangussu; V Landini; T Andrade; M Sartori; L Petrus; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

10.  Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases.

Authors:  Rong Chen; Lisong Shi; Jörg Hakenberg; Brian Naughton; Pamela Sklar; Jianguo Zhang; Hanlin Zhou; Lifeng Tian; Om Prakash; Mathieu Lemire; Patrick Sleiman; Wei-Yi Cheng; Wanting Chen; Hardik Shah; Yulan Shen; Menachem Fromer; Larsson Omberg; Matthew A Deardorff; Elaine Zackai; Jason R Bobe; Elissa Levin; Thomas J Hudson; Leif Groop; Jun Wang; Hakon Hakonarson; Anne Wojcicki; George A Diaz; Lisa Edelmann; Eric E Schadt; Stephen H Friend
Journal:  Nat Biotechnol       Date:  2016-04-11       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.